In January 2019, we acquired Amplity Health (fka Publicis Health Solutions), a leading pharmaceutical contract commercial services organization, from Publicis Groupe. Amplity Health provides customized, live channel healthcare sales, service and clinical solutions for pharmaceutical, biotechnology, medical device and diagnostics companies and offers these services through a range of brands including Publicis Touchpoint Solutions, PDI, Tardis Medical, Phrequency and CustomPoint Recruiting.
In January 2020, Amplity acquired RealHealthData, a pharmaceutical data services provider specializing in providing patient and provider insights.
In March 2015, we provided capital to support the growth of CHE Behavioral Health Services, the leading provider of behavioral health services to senior care facilities. Founded in 1995, CHE serves over 1,000 facilities nationwide with a staff of over 700 clinicians.
In 2022, we established Gracent, a provider of multidisciplinary services including applied behavioral analysis, speech therapies, neuropsychology, and diagnostics to support people with autism and related disorders. Gracent operates a network of outpatient clinics in the Illinois and Texas markets.
In October 2014, we acquired a majority stake in INtuitive Health (fka Legacy ER & Urgent Care). INtuitive Health was founded in 2008 to offer a unique healthcare services model combining both urgent care and emergency care in an outsourced / freestanding format. INtuitive Health’s unique hybrid model has distinct advantages relative to competition, as it triages patients appropriately based on the acuity of their cases, avoiding unnecessary costs of unwarranted emergency care. The Company currently operates clinics in the Dallas, Texas area.
In July 2012, we provided capital to support the carve-out of the specialty pharmacy operations of Modern HEALTHcare. The new company, called ModernHEALTH Specialty Pharmacy, also simultaneously acquired the specialty pharmacy operations of A-Med Healthcare. Modern is based in Monrovia California, serving patients with complex pharmaceutical therapies including HIV, Cystic Fibrosis, Transplant, Hepatitis C, and Multiple Sclerosis, among others. The Company’s BioFusion division is a national leader in IVIG infusion therapy.
In September 2017, we acquired a majority stake in Sequel Youth and Family Services. Sequel is a leading, national provider of diversified behavioral health services for children, adolescents and adults with behavioral, emotional or physical challenges. Founded in 1999, the Company operates over 40 programs across 21 states.
Since our initial investment, we have acquired Rebecca & Aaron Schools (2017) and Pine Cone Therapies (2020).